MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in MiNK Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −7 vs. Q2 2023
- Shares held
- 723.5K
- −751.9K (−51.0%) vs. Q2 2023
- Total value
- $800.0K
- −$2.29M (−74.1%) vs. Q2 2023
- New holders
- 1
- 7 more added
- Sold out
- 8
- 17 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.39M |
| Q1 2026 | 23 | $1.34M |
| Q4 2025 | 25 | $1.71M |
| Q3 2025 | 18 | $1.28M |
| Q2 2025 | 19 | $460.8K |
| Q1 2025 | 17 | $544.2K |
| Q4 2024 | 23 | $564.9K |
| Q3 2024 | 26 | $632.3K |
| Q2 2024 | 31 | $847.8K |
| Q1 2024 | 34 | $848.1K |
| Q4 2023 | 36 | $1.05M |
| Q3 2023 | 36 | $800.0K |
| Q2 2023 | 45 | $3.10M |
| Q1 2023 | 12 | $1.15M |
| Q4 2022 | 16 | $1.70M |
| Q3 2022 | 11 | $1.00M |
| Q2 2022 | 13 | $504.0K |
| Q1 2022 | 25 | $1.76M |
| Q4 2021 | 21 | $5.96M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding MiNK Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 234,182 | $257.6K | 0.00% | −7,001−2.9% | Reduced |
| Geode Capital Management, LLC | 90,164 | $105.5K | 0.00% | −2,559−2.8% | Reduced |
| BlackRock Inc. | 80,499 | $88.5K | 0.00% | −1,530−1.9% | Reduced |
| Captrust Financial Advisors | 61,799 | $68.0K | 0.00% | +22,257+56.3% | Added |
| Renaissance Technologies LLC | 57,704 | $63.0K | 0.00% | −87,824−60.3% | Reduced |
| Oracle Investment Management Inc | 36,898 | $40.6K | 0.06% | −13,563−26.9% | Reduced |
| State Street Corp | 25,700 | $30.1K | 0.00% | −3,073−10.7% | Reduced |
| Bank of America Corp | 25,402 | $27.9K | 0.00% | −953−3.6% | Reduced |
| UBS Oconnor LLC | 21,590 | $25.3K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 17,312 | $19.0K | 0.00% | +298+1.8% | Added |
| Wells Fargo & Company | 12,125 | $13.3K | 0.00% | −15,298−55.8% | Reduced |
| HighTower Advisors, LLC | 16,413 | $13.0K | 0.00% | −562−3.3% | Reduced |
| Northern Trust Corp | 11,125 | $12.2K | 0.00% | −20.0% | Reduced |
| Morgan Stanley | 8,097 | $8.91K | 0.00% | −4,090−33.6% | Reduced |
| Tower Research Capital LLC (TRC) | 7,695 | $8.46K | 0.00% | −3,454−31.0% | Reduced |
| California State Teachers Retirement System | 5,066 | $5.93K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,547 | $3.90K | 0.00% | +397+12.6% | Added |
| Qube Research & Technologies Ltd | 1,941 | $2.27K | 0.00% | +1,941 | New |
| Artal Group S.A. | 1,916 | $2.00K | 0.00% | −226,300−99.2% | Reduced |
| Lazard Asset Management LLC | 1,294 | $1.00K | 0.00% | +104+8.7% | Added |
| Royal Bank of Canada | 649 | $1.00K | 0.00% | +111+20.6% | Added |
| Covestor Ltd | 1,078 | $1.00K | 0.00% | +494+84.6% | Added |
| Advisor Group Holdings, Inc. | 402 | $440 | 0.00% | +49+13.9% | Added |
| Chilton Capital Management LLC | 309 | $340 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 185 | $204 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 107 | $125 | 0.00% | 00.0% | Unchanged |
| Quadrant Capital Group LLC | 72 | $80 | 0.00% | −96−57.1% | Reduced |
| FMR LLC | 60 | $70 | 0.00% | −9,434−99.4% | Reduced |
| Sittner & Nelson, LLC | 58 | $64 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 43 | $47 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 18 | $20 | 0.00% | −46−71.9% | Reduced |
| Lindbrook Capital, LLC | 14 | $15 | 0.00% | −12−46.2% | Reduced |
| Parallel Advisors, LLC | 10 | $11 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 5 | $6 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 2 | $3 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −324,867−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −51,048−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,232−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −11,544−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| First Command Bank | – | – | – | – | Not filed |
| First Command Financial Services, Inc. | – | – | – | – | Not filed |